GeoVax Labs (GOVX) Other financing activities (2020 - 2025)
GeoVax Labs (GOVX) posted quarterly Other financing activities of $156000.0 for Q3 2025, down 84.05% year-over-year from $977770.0 in Q3 2024, and down 84.05% quarter-over-quarter from $977770.0 in Q3 2024.
GeoVax Labs (GOVX) Other financing activities (2020 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Other financing activities for 6 consecutive years, with $156000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other financing activities fell 84.05% year-over-year to $156000.0; the TTM figure through Dec 2025 stood at $1.1 million (down 100.0% YoY), while the FY2025 annual figure was $156209.0, down 93.4% from the prior year.
- Other financing activities fell to $156000.0 in Q3 2025 per GOVX's latest filing, from $977770.0 in the prior quarter.
- Across five years, Other financing activities topped out at $1389.4 billion in Q2 2024 and bottomed at $24.0 in Q1 2022.
- Historically, Other financing activities has averaged $198.5 billion across 5 years, with a median of $977770.0 in 2024.
- Annual changes were most pronounced in 2022 — Other financing activities slumped 100.0% — and 2025, when it tumbled 84.05%.
- GeoVax Labs' Other financing activities stood at $3.2 million in 2021, then sank by 99.98% to $567.0 in 2022, then surged by 716380.07% to $4.1 million in 2023, then plunged by 75.93% to $977770.0 in 2024, then sank by 84.05% to $156000.0 in 2025.
- Business Quant data shows GOVX's Other financing activities at $156000.0 in Q3 2025, $977770.0 in Q3 2024, and $1389.4 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2024 | 977,770.00 |
| Sep 30, 2024 | 977,770.00 |
| Jun 30, 2024 | 1,389.36 Bn |
| Jun 30, 2024 | 1,389.36 Bn |
| Dec 31, 2023 | 4.06 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Jun 30, 2022 | 567.00 |
| Jun 30, 2022 | 567.00 |
| Mar 31, 2022 | 24.00 |
| Mar 31, 2022 | 24.00 |
| Mar 31, 2021 | 3.17 Mn |
| Mar 31, 2021 | 3.17 Mn |
| Dec 31, 2020 | 2,500.00 |
| Dec 31, 2020 | 2,500.00 |